Intrinsic Capital Partners is an investment firm specializing in life science and technology businesses within the alternative therapeutics market. The company employs an operator-centric investment model to build and scale industry-leading companies, focusing on unmet needs across the supply chain. Intrinsic Capital Partners leverages its seasoned team's expertise to drive growth and create value in its diverse portfolio.
Recent Transactions involving Intrinsic Capital Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
ACT Laboratories, Inc. Expands into Massachusetts with the Acquisition of CDX Analytics |
CDX Analytics |
ACT Laboratories |
Intrinsic Capital Partners |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →